Changshui Yu

Changshui Yu

Auto-generated profile, based on publicly available information

Changshui Yu

Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, Jiangsu, China

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2026 in Materials Today Bio
Verified
Journal Article
Open access
ZLZhen Li
Zhen Li
CYChangshui Yu
Changshui Yu
HCHongyu Che
Hongyu Che
DXDuo Xu
Duo Xu
DLDong Lu
Dong Lu
RYRutong Yu
Rutong Yu
Glioblastoma (GBM) remains poorly responsive to immunotherapy due to restricted brain delivery and a profoundly immunosuppressive “cold” microenvironment. Here, we report ultrasmall manganese-doped carbon dots enriched with surface amino and carboxyl groups (Mn-CDs) as a self-adjuvanted nanotherapeutic that integrates dual targeting with a synergistic immune cascade. Mn-CDs exploit LAT1-mediated transport to traverse the blood–brain barrier and preferentially accumulate in glioma tissue, while their intrinsic positive surface potential drives mitochondrial tropism via the mitochondrial membrane potential. Once localized to mitochondria, mixed-valence Mn centers catalyze Fenton-like reactions, amplifying oxidative stress and inducing mitochondrial depolarization and ultrastructural disruption. This organelle-localized stress is coupled to robust activation of the cGAS–STING–TBK1–IRF3 axis, leading to elevated IFN-I signaling and proinflammatory chemokine production. In parallel, Mn-CDs elicit immunogenic cell death, as evidenced by calreticulin (CRT) exposure, HMGB1 release, and extracellular ATP emission, thereby promoting dendritic cell maturation and cytotoxic T-cell infiltration. In orthotopic syngeneic GBM models, Mn-CDs remodel the immunosuppressive tumor microenvironment, suppress intracranial tumor progression, and prolong survival with favorable biosafety. Collectively, this work establishes a dual-targeted Mn-based carbon nanoplatform that converts GBM toward an immune-responsive state through convergent cGAS–STING activation and ICD-driven immune priming.